Molecular Assemblies Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
51
- Latest Deal Type
-
M&A
Molecular Assemblies General Information
Description
Developer of enzymatic deoxyribonucleic acid synthesis technology designed to power next-generation deoxyribonucleic acid-based products. The company's technology is capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology, and other related fields, providing researchers with long, high-quality, sequence-specific molecules that are reliable and affordable.
Contact Information
Website
www.molecularassemblies.com(Operating Subsidiary)
Corporate Office
- 9276 Scranton Road
- Suite 300
- San Diego, CA 92121
- United States
Corporate Office
- 9276 Scranton Road
- Suite 300
- San Diego, CA 92121
- United States
Molecular Assemblies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Merger/Acquisition | 28-Jan-2025 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series B) | 21-Sep-2022 | Completed | Generating Revenue | |||
| 10. Grant | 19-Oct-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B) | 22-Sep-2021 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 15-Apr-2021 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 06-Feb-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 10-Jul-2020 | Cancelled | Generating Revenue | |||
| 5. Debt - PPP | 28-Apr-2020 | $325K | $6.48M | Completed | Generating Revenue | |
| 4. Seed Round | 08-May-2019 | $6.48M | $6.48M | Completed | Generating Revenue |
Molecular Assemblies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Molecular Assemblies Comparisons
Industry
Financing
Details
Molecular Assemblies Competitors (15)
One of Molecular Assemblies’s 15 competitors is Ribbon Biolabs, a Venture Capital-Backed company based in Vienna, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ribbon Biolabs | Venture Capital-Backed | Vienna, Austria | ||||
| Ansa Biotechnologies | Venture Capital-Backed | Emeryville, CA | ||||
| DNA Script | Venture Capital-Backed | Paris, France | ||||
| Telesis Bio | Formerly VC-backed | San Diego, CA | ||||
| Twist Bioscience | Formerly VC-backed | South San Francisco, CA |
Molecular Assemblies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Molecular Assemblies Patents
Molecular Assemblies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4499824-A1 | Methods and apparatus for synthesizing nucleic acids | Pending | 25-Mar-2022 | ||
| US-20230332140-A1 | Layered coding architectures for nucleic acid memory | Pending | 25-Aug-2020 | ||
| AU-2021285906-A1 | Modified template-independent enzymes for polydeoxynucleotide synthesis | Pending | 03-Jun-2020 | ||
| EP-4162035-A2 | Modified template-independent enzymes for polydeoxynucleotide synthesis | Pending | 03-Jun-2020 | ||
| CA-3185851-A1 | Modified template-independent enzymes for polydeoxynucleotide synthesis | Pending | 03-Jun-2020 | C12N9/1264 |
Molecular Assemblies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Molecular Assemblies Former Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 11.2 Capital | Venture Capital | Minority | ||
| Agilent Technologies | Corporation | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Argonautic Ventures | Venture Capital | Minority | ||
| Casdin Capital | Venture Capital | Minority |
Molecular Assemblies FAQs
-
When was Molecular Assemblies founded?
Molecular Assemblies was founded in 2013.
-
Where is Molecular Assemblies headquartered?
Molecular Assemblies is headquartered in San Diego, CA.
-
What is the size of Molecular Assemblies?
Molecular Assemblies has 51 total employees.
-
What industry is Molecular Assemblies in?
Molecular Assemblies’s primary industry is Biotechnology.
-
Is Molecular Assemblies a private or public company?
Molecular Assemblies is a Private company.
-
What is Molecular Assemblies’s current revenue?
The current revenue for Molecular Assemblies is .
-
How much funding has Molecular Assemblies raised over time?
Molecular Assemblies has raised $76.6M.
-
Who are Molecular Assemblies’s investors?
11.2 Capital, Agilent Technologies, Alexandria Venture Investments, Argonautic Ventures, and Casdin Capital are 5 of 19 investors who have invested in Molecular Assemblies.
-
Who are Molecular Assemblies’s competitors?
Ribbon Biolabs, Ansa Biotechnologies, DNA Script, Telesis Bio, and Twist Bioscience are some of the 15 competitors of Molecular Assemblies.
-
When was Molecular Assemblies acquired?
Molecular Assemblies was acquired on 28-Jan-2025.
-
Who acquired Molecular Assemblies?
Molecular Assemblies was acquired by Maravai LifeSciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
